Trendlines sets up JV in Shanghai
THE Trendlines Group on Monday announced that it has together with Chinese private equity firm Shoushan Wealth Holdings, set up China-Israel New Trend (Taizhou) Medical Technology.
The latter, which will be based in Shanghai, is a joint venture to help Trendlines' medical sector portfolio companies as well as other Israeli, Singaporean and other medical companies penetrate the Chinese market.
This includes helping companies establish manufacturing capabilities in China, obtain regulatory approval for the sale of products in China, and manage strategic partner relationships.
Trendlines and Shoushan also intend to raise venture funds (in US dollar and Chinese renminbi) to invest in global medical technology companies.
Trendlines is a Catalist-listed, Israeli and Singapore-based incubator that invests in and nurtures early-stage medical and agricultural technology companies.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Google, US clash over search advertising as trial winds down
Apple rallies most in 18 months on upbeat forecast, buyback
US: Wall St opens sharply higher on soft jobs data
HSBC has no plans to dispose of further businesses, chairman says
Glencore Group nears deal for Shell’s Singapore oil refinery
Chinese share of French EV market slumps after incentives curbed